Literature DB >> 11847376

The changing epidemiology of recurrent pyogenic cholangitis.

C M Lo1, S T Fan, J Wong.   

Abstract

Recurrent pyogenic cholangitis is prevalent in Hong Kong and East Asia. While the recent influx of Asian immigrants has resulted in more cases appearing in the West, over the past three decades, the overall incidence in East Asia has been in decline. The experience of the Queen Mary Hospital and other hospitals in the region has been confirmed by comprehensive surveys. The decline in incidence has been attributed to the improved economic situation and living standards with the associated westernisation of diet.

Entities:  

Year:  1997        PMID： 11847376

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN： 1024-2708            Impact factor:   2.227


  11 in total

1.  Surgical management of recurrent pyogenic cholangitis: 10 years of experience in a tertiary referral centre in Hong Kong.

Authors:  Michael Co; Suet Ying Pang; Kin Yuen Wong; Wai Kit Ip; Wai Key Yuen
Journal:  HPB (Oxford)       Date:  2013-11-07       Impact factor: 3.647

Review 2.  Gastrointestinal Manifestations of Cystic Fibrosis.

Authors:  Thomas Kelly; James Buxbaum
Journal:  Dig Dis Sci       Date:  2015-02-04       Impact factor: 3.199

3.  Multidisciplinary Treatment of Cystic Fibrosis-Related Recurrent Pyogenic Cholangitis (CF-RPC).

Authors:  James Buxbaum; Nancy Nguyen; Sujit Kulkarni; Suzanne Palmer; Adupa Rao; Robert Selby
Journal:  Dig Dis Sci       Date:  2015-01-29       Impact factor: 3.199

4.  Clostridium bacteraemia characterised by 16S ribosomal RNA gene sequencing.

Authors:  P C Y Woo; S K P Lau; K-M Chan; A M Y Fung; B S F Tang; K-Y Yuen
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

5.  Outcome of surgical treatment for recurrent pyogenic cholangitis: a single-centre study.

Authors:  Kit-fai Lee; Ching-ning Chong; Daniel Ng; Yue-sun Cheung; Wilson Ng; John Wong; Paul Lai
Journal:  HPB (Oxford)       Date:  2009-02       Impact factor: 3.647

6.  Recurrent pyogenic cholangitis with hepatolithiasis--the role of surgical therapy in North America.

Authors:  Wigdan Al-Sukhni; Steven Gallinger; Ariella Pratzer; Alice Wei; C S Ho; Paul Kortan; Bryce R Taylor; David R Grant; Ian McGilvray; Mark S Cattral; Bernard Langer; Paul D Greig
Journal:  J Gastrointest Surg       Date:  2007-11-13       Impact factor: 3.452

7.  Robotic Liver Resection For Primary Hepatolithiasis: Is It Beneficial?

Authors:  Kit-Fai Lee; Anthony K W Fong; Charing C N Chong; Sunny Y S Cheung; John Wong; Paul B S Lai
Journal:  World J Surg       Date:  2016-10       Impact factor: 3.352

8.  Outcome of surgery for recurrent pyogenic cholangitis: a single center experience.

Authors:  Sukanta Ray; Sumit Sanyal; Kshaunish Das; Ranajoy Ghosh; Somak Das; Sujan Khamrui; Avik Sarkar; Gautam Chattopadhyyay
Journal:  HPB (Oxford)       Date:  2016-06-28       Impact factor: 3.647

9.  Recurrent pyogenic cholangitis treated by left hepatectomy.

Authors:  Sukanta Ray
Journal:  Indian J Surg       Date:  2011-04-15       Impact factor: 0.656

10.  The role of endoscopy in the management of recurrent pyogenic cholangitis: a review.

Authors:  Omar Metwally; Kevin Man
Journal:  J Community Hosp Intern Med Perspect       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.